(Q54118805)

25 May 2018

review article

1 reference

title

Insulin and polycystic ovary syndrome: a new look at an old subject. (English)

1 reference

25 May 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

Ciampelli M

1

1 reference

25 May 2018

Lanzone A

series ordinal

2

1 reference

25 May 2018

publication date

1 August 1998

1 reference

25 May 2018

Gynecological Endocrinology

published in

1 reference

25 May 2018

volume

12

1 reference

25 May 2018

issue

4

1 reference

25 May 2018

page(s)

277-292

1 reference

25 May 2018

Polycystic ovary syndrome: a changing perspective

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The gonadotropic function of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Reproductive health and polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Nutrition, hormones, and breast cancer: is insulin the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Gestational diabetes. Incidence, maternal characteristics, and perinatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Effect of insulin on growth of cultured human arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Fasting insulin in relation to subsequent blood pressure changes and hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The insulin receptor: molecular biology and transmembrane signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The insulin receptor and the molecular mechanism of insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Evidence for insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The role of adenosine in insulin action coupling in rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Decreased insulin removal contributes to hyperinsulinemia in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Effect of opioid blockade on insulin metabolism in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Perspective in the treatment of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Morphine and β-endorphin influence the secretion of the endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

beta-Endorphin and beta-lipotropin plasma levels in hirsute women: correlation with body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Association of Metformin's Effect to Increase Insulin-Stimulated Glucose Transport With Potentiation of Insulin-Induced Translocation of Glucose Transporters From Intracellular Pool to Plasma Membrane in Rat Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

β-Endorphin Infusion Restores Acute Insulin Responses to Glucose in Type-2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599809015601

10.3109/09513599809015601

21 January 2018

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018